Indication
Liver Metastasis Colon Cancer
10 clinical trials
13 products
2 drugs
Clinical trial
An Open-Label, Multicenter, Non-Randomized, Dose-Confirmation and Cohort-Expansion Phase 1b Study to Evaluate the Safety, Tolerability, and Anti-Tumor Activity of ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal CancerStatus: Active (not recruiting), Estimated PCD: 2024-07-31
Product
BI 754091Product
VSV-GP128Product
ATP128Product
DNX-2440Clinical trial
A Phase I Safety and Window-of-opportunity Study of Preoperative Intratumoral Injection of OX40-ligand Expressing Oncolytic Adenovirus (DNX-2440) in Patients With Resectable Liver MetastasisStatus: , Estimated PCD: 2026-07-31
Clinical trial
Precision Medicine for Liver Tumours With Quantitative Magnetic Resonance Imaging and Whole Genome SequencingStatus: Active (not recruiting), Estimated PCD: 2023-12-31
Product
Whole Genome SequencingClinical trial
On-treatment Biomarkers in Metastatic Colorectal Cancer for Life: The On-CALL StudyStatus: Recruiting, Estimated PCD: 2026-12-01
Drug
CisplatinClinical trial
Application of High-Dose Insulin Therapy Using a Hyperinsulinemic Normoglycemic Clamp to Improve Liver Function and RegenerationStatus: Recruiting, Estimated PCD: 2025-01-01
Product
High-Dose InsulinClinical trial
Immunotherapy Combined With Yttrium-90 RadioEmbolization in the Treatment of Colorectal Cancer With Liver Metastases [iRE-C - Clinical Trial]Status: , Estimated PCD: 2023-12-31
Drug
AN0025Clinical trial
Targeted Treatment Based on ctDNA Genotyping Combined With Tislelizumab and HAIC as Salvage Treatment for Advanced Colorectal Cancer Liver Metastasis Failed From Standard Systemic Treatment (SALVLIV Trial)Status: Recruiting, Estimated PCD: 2026-01-23
Clinical trial
Immune Response to Irreversible Electroporation (NanoKnife ®) and a Checkpoint Inhibitor With or Without CpG Oligodeoxynucleotides for the Treatment of Stage IV Colorectal CancerStatus: Not yet recruiting, Estimated PCD: 2026-12-01
Product
IREClinical trial
COLLISION RELAPSE Trial - Recurrent Colorectal Liver Metastases: Repeat Local Treatment +/- Neoadjuvant Systemic Therapy - a Phase III Prospective Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2027-05-01
Product
Neoadjuvant systemic therapyClinical trial
Randomized, Multicenter Phase II Study of Monoclonal FOLFOX6m + mAb Alone or in Combination With Liver Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease Limited to the Liver With Poor PrognosisStatus: Recruiting, Estimated PCD: 2024-01-15
Product
FOLFOX regimenProduct
Anti-EGFR or BevacizumabProduct
LIVERPEARLS-Irinotecan